388 related articles for article (PubMed ID: 7018057)
1. Platelet preservation during cardiopulmonary bypass (CPB) with prostaglandin (PGE1) and prostacyclin (PGI2).
van den Dungen JJ; Velders AJ; Karliczek GF; Homan van der Heide JN; Wildevuur CR
Trans Am Soc Artif Intern Organs; 1980; 26():481-6. PubMed ID: 7018057
[No Abstract] [Full Text] [Related]
2. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
Coppe D; Sobel M; Seamans L; Levine F; Salzman E
J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
[TBL] [Abstract][Full Text] [Related]
3. [Experimental studies on platelet preservation with prostaglandin I2 and its derivative (OP-41483) during cardiopulmonary bypass].
Takeda H
Hokkaido Igaku Zasshi; 1989 Jul; 64(4):500-11. PubMed ID: 2511131
[TBL] [Abstract][Full Text] [Related]
4. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
5. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Ubatuba FB; Moncada S; Vane JR
Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
[TBL] [Abstract][Full Text] [Related]
6. Some actions of prostacyclin (PGI2) on the cardiovascular system and the gastric microcirculation.
Whittle BJ; Moncada S; Vane JR
Acta Biol Med Ger; 1978; 37(5-6):725-8. PubMed ID: 369255
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1978 Sep; 16(3):373-88. PubMed ID: 364545
[TBL] [Abstract][Full Text] [Related]
8. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
Wong PY; McGiff JC; Sun FF; Lee WH
Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin releasing polymers - stability and efficacy.
McRea JC; Ebert CD; Kim SW
Trans Am Soc Artif Intern Organs; 1981; 27():511-6. PubMed ID: 7036503
[TBL] [Abstract][Full Text] [Related]
10. Quantitation of platelet lysis, platelet consumption on oxygenator, and stabilization of platelet membrane with prostacyclin and ibuprofen during cardiopulmonary bypass surgery in dogs.
Dewanjee MK; Vogel SR; Peterson KA; Lim MF; Kaye MP
Trans Am Soc Artif Intern Organs; 1981; 27():197-202. PubMed ID: 7036497
[No Abstract] [Full Text] [Related]
11. Histologic and hemodynamic effects of prostacyclin and prostaglandin E1 following oleic acid infusion.
Slotman GJ; Machiedo GW; Casey KF; Lyons MJ
Surgery; 1982 Jul; 92(1):93-9. PubMed ID: 7046123
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
13. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
Bult H; Wechsung E; Houvenaghel A; Herman AG
Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
[No Abstract] [Full Text] [Related]
14. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic side effects of prostaglandin E1 in patients before and during cardiopulmonary bypass.
Karliczek G; van den Dungen JJ; Brenken U; Eijsman L; Kootstra GJ; Homan van der Heide JN; Wildevuur CR
Thorac Cardiovasc Surg; 1981 Feb; 29(1):55-9. PubMed ID: 6164120
[TBL] [Abstract][Full Text] [Related]
16. The effect of prostaglandin E1 in patients undergoing clinical cardiopulmonary bypass.
van den Dungen JJ; Karliczek GF; Brenken U; van der Heide JN; Wildevuur CR
Ann Thorac Surg; 1983 Apr; 35(4):406-14. PubMed ID: 6682305
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
18. [Clinical study of prostacyclin in extracorporeal circulation. Effects on hemodynamics and coagulation].
Fabiani JN; Bunting S; Terrier E; O'Grady J; Fontaine B; Prigent C; Carpentier A; Vane J; Dubost C
Arch Mal Coeur Vaiss; 1982 Mar; 75(3):241-8. PubMed ID: 6807240
[TBL] [Abstract][Full Text] [Related]
19. The general pharmacology of prostacyclin PGI2, (PGX): a new prostaglandin especially active on the cardivascular system.
Weeks JR
Acta Biol Med Ger; 1978; 37(5-6):707-14. PubMed ID: 369253
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
Hyman AL; Kadowitz PJ
Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]